AOD-9604

Lipolysis

Modified HGH(176-191) C-terminal fragment studied for fat oxidation without raising GH or IGF-1.

AOD-9604 is the tail end of the growth hormone molecule — the specific fragment responsible for GH's fat-burning action, snipped away from the parts that raise blood sugar or grow tissue. The idea is to get GH's lipolytic (fat-releasing) effect without elevating GH or IGF-1 at all, so none of the growth-related risks apply. In practice the fat-loss effect is modest and the human data is thin, but its very clean safety profile makes it a low-stakes option, and there are early hints of joint and cartilage benefit too.

Dose
300 mcg subQ daily, AM fasted.
Reconstitute
10 mg + 2 mL = 5 mg/mL. 6 units = 300 mcg.
Schedule
5–6×/week, 12+ week cycles.
Half-life
~30 minutes.
Timing
AM fasted, 30 min before food.
Risks
Very mild. Some users report nausea.

within Growth Hormone — Direct Anabolic